Volume 8, Issue 5, September 2022

Focus on optimizing treatment of coronary heart disease

• Extract
• View article

Statin but not aspirin treatment is associated with reduced cardiovascular risk in patients with diabetes without obstructive coronary artery disease: a cohort study from the Western Denmark Heart Registry

• Abstract
• View article
• Supplementary data

Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway

• Abstract
• View article
• Supplementary data

Impact of chronic kidney disease on the pharmacodynamic and pharmacokinetic effects of ticagrelor in patients with diabetes mellitus and coronary artery disease

• Abstract
• View article
• Supplementary data

Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

• Abstracts
• View article
• Supplementary data

Concerns about the use of digoxin in acute coronary syndromes

• Abstracts
• View article
• Supplementary data

Incidence, associated outcomes, and predictors of upper gastrointestinal bleeding following acute myocardial infarction: a SWEDEHEART-based nationwide cohort study

• Abstracts
• View article
• Supplementary data

Guided and unguided de-escalation from potent P2Y₁₂ inhibitors among patients with acute coronary syndrome: a meta-analysis

• Abstracts
• View article
• Supplementary data

Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials

• Abstract
• View article
• Supplementary data

The association of PRECISE-DAPT score with ischaemic outcomes in patients taking dual antiplatelet therapy following percutaneous coronary intervention: a meta-analysis

• Abstract
• View article
• Supplementary data

Efficacy and safety of dual-pathway inhibition in patients with cardiovascular disease: a meta-analysis of 49 802 patients from 7 randomized trials

• Abstract
• View article
• Supplementary data

Beta blockers and long-term outcome after coronary artery bypass grafting: a nationwide observational study

• Abstract
• View article
• Supplementary data

Updated ACC/AHA/HFSA 2022 guidelines on heart failure: what is new? From epidemiology to clinical management

• Extract
• View article

Future of antithrombotic therapy for heart failure with coronary artery disease

• Extract
• View article

Late breaking clinical trials at ACC 22

• Extract
• View article

Need for more evidence of safety in the pharmacological therapy of anaemia in chronic kidney disease: a cardiovascular perspective

• Extract
• View article